Aurore Viviane Fifi-Mah

8PUBLICATIONS
36CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyAutoimmunityRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 04, 2026
Characterizing Persistent CNS MRI Enhancement in Patients With Treated Neurosarcoidosis.

|Sep 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases.

Carrie Ye, Roko P A Nikolic, May Choi

|Sep 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides.

Carrie Ye, Roko P A Nikolic, May Choi

|Dec 16, 2024
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO).

Jenny Xiaoyu Li, Marie Hudson, Carrie Ye

|Feb 01, 2024
Investigating the Influence of Patient Eligibility Characteristics on the Number of Deferrable Rheumatologist Visits: Planning for a Patient-Initiated Follow-Up Strategy.

Shakeel Subdar, Kiran Dhiman, Nicole M S Hartfeld

|Jul 17, 2019
Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist.

Shahin Jamal, Marie Hudson, Aurore Fifi-Mah

Pageof 2

Frequent Collaborators

3 joint publications

Sabrina Hoa

3 joint publications

Shahin Jamal

3 joint publications

Janet Pope

3 joint publications

Glen S Hazlewood